Dexcom CEO Kevin Sayer touted the company’s recent efforts to expand coverage of CGMs for people with Type 2 diabetes. On a May 1 earnings call, the CEO told investors that all three major U.S.

Investors remain optimistic about TNDM, courtesy of its strong t:slim X2 performance and breakthrough innovations.

Impressive Product Innovation Continues: Tandem Diabetes' flagship t:slim X2 insulin pump software, launched in 2023 in the United States, became compatible with Dexcom G7 and with Dexcom G6 ...

Gwyneth Paltrow is once again at the center of social media buzz, for what fans believe may be a health-related device ...

Just a few weeks after Dexcom’s Stelo became the first over-the-counter continuous glucose ... Like Stelo, Lingo takes the form of a patch with a tiny needle that pierces the skin and is worn ...

I would now like to hand the conference over to Blake Beber ... Now to touch on CGM integrations, we will support the 15-day Dexcom G7 sensor at launch. We are currently integrated with Dexcom ...

Goldman Sachs forecasts strong growth for diabetes tech, backing Dexcom and Insulet while rating Tandem and Beta Bionics as ...

Let’s do this over the next 12 months ... It offers various medical devices and products, including Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE.

Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered ...

STALKER 2 patch 1.1 promised fixes for over 1,800 issues, including a first set of improvements for the game’s A-Life 2.0 system. Since launch, A-Life 2.0 has been a major source of ...

This is the first post-launch patch with over 650 different bugs and issues addressed across both Xbox Series X|S and PC, though the studio acknowledges that there’s a good bit more work still ...